GSK, 23andMe to apply personal genetics to drug discovery

New partnership is part of GSK ’s R&D face-lift, which includes an increased focus on immune system targets

Source: NanoFocus - July 27, 2018 Category: Nanotechnology Authors: Ryan Cross Source Type: research